— Know what they know.
Not Investment Advice
Also trades as: 0I0J.L (LSE) · $vol 0M

CLX NYSE

The Clorox Company
1W: +4.4% 1M: -1.7% 3M: -23.0% YTD: -4.6% 1Y: -28.3% 3Y: -38.5% 5Y: -39.2%
$95.11
-0.06 (-0.06%)
 
Weekly Expected Move ±6.6%
$79 $85 $90 $96 $102
NYSE · Consumer Defensive · Household & Personal Products · Alpha Radar Neutral · Power 48 · $11.5B mcap · 121M float · 2.23% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.6 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 26.1%  ·  5Y Avg: 12.7%
Cost Advantage
62
Intangibles
50
Switching Cost
27
Network Effect
23
Scale ★
70
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CLX shows a Weak competitive edge (45.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 26.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$83
Low
$94
Avg Target
$110
High
Based on 6 analysts since Apr 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 4Hold: 19Sell: 5Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$104.22
Analysts9
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-01 Morgan Stanley $125 $97 -28 +9.9% $88.25
2026-05-01 Goldman Sachs Bonnie Herzog $94 $83 -11 -5.4% $87.73
2026-05-01 Evercore ISI Javier Escalante $140 $110 -30 +24.6% $88.30
2026-05-01 Deutsche Bank Steve Powers $114 $91 -23 -5.6% $96.44
2026-05-01 UBS $121 $96 -25 -0.5% $96.44
2026-05-01 Barclays $109 $85 -24 -11.9% $96.44
2026-04-21 Jefferies Kaumil Gajrawala $152 $139 -13 +38.5% $100.34
2026-04-09 RBC Capital $132 $127 -5 +18.0% $107.62
2026-04-08 Wells Fargo $125 $110 -15 +4.1% $105.67
2026-02-17 Wells Fargo Chris Carey $115 $125 +10 -0.7% $125.94
2026-02-13 Redburn Partners Initiated $117 -6.1% $124.64
2026-02-04 UBS Peter Grom $115 $121 +6 +3.1% $117.35
2026-02-04 RBC Capital $138 $132 -6 +13.2% $116.62
2026-01-23 Deutsche Bank $151 $114 -37 -1.1% $115.22
2026-01-23 Wells Fargo $108 $115 +7 +2.5% $112.20
2026-01-16 Barclays $112 $109 -3 -0.2% $109.26
2026-01-14 UBS Peter Grom $119 $115 -4 +3.9% $110.64
2026-01-07 Goldman Sachs $132 $94 -38 -6.6% $100.61
2026-01-05 Wells Fargo $117 $108 -9 +8.4% $99.67
2025-11-04 Morgan Stanley Dara Mohsenian $150 $125 -25 +14.2% $109.42
2025-11-04 UBS Peter Grom $128 $119 -9 +9.0% $109.14
2025-11-04 Wells Fargo $142 $117 -25 +7.2% $109.14
2025-11-04 Jefferies Kaumil Gajrawala $187 $152 -35 +39.3% $109.14
2025-10-08 UBS $148 $128 -20 +7.7% $118.81
2025-10-01 Barclays $119 $112 -7 -8.7% $122.67
2025-07-15 Barclays Lauren Lieberman $129 $119 -10 -6.1% $126.78
2025-05-07 Barclays Lauren Lieberman $139 $129 -10 -4.5% $135.05
2025-05-06 Evercore ISI Javier Escalante Initiated $140 +3.7% $135.05
2025-05-06 Morgan Stanley Dara Mohsenian $145 $150 +5 +11.1% $135.05
2025-05-06 Wells Fargo Chris Carey $135 $142 +7 +6.3% $133.64
2025-03-27 Barclays Lauren Lieberman $122 $139 +17 -4.6% $145.63
2024-10-08 Goldman Sachs Bonnie Herzog Initiated $132 -17.3% $159.56
2024-10-01 Jefferies Kaumil Gajrawala $145 $187 +42 +12.8% $165.83
2024-07-19 Barclays Lauren Lieberman $101 $122 +21 -10.5% $136.31
2024-05-02 Wells Fargo Chris Carey $135 $135 0 -3.3% $139.63
2024-03-26 Jefferies Kaumil Gajrawala $145 $145 0 -3.7% $150.52
2024-01-30 RBC Capital Nik Modi Initiated $138 -5.5% $145.97
2023-10-05 Raymond James Olivia Tong $165 $185 +20 +48.4% $124.69
2023-09-08 J.P. Morgan Ken Goldman $126 $153 +27 -1.4% $155.10
2023-02-03 Morgan Stanley $137 $145 +8 +2.8% $141.00
2023-02-03 Raymond James $160 $165 +5 +17.0% $141.00
2023-02-01 Jefferies $185 $145 -40 +1.2% $143.32
2023-01-03 Wells Fargo $130 $135 +5 -3.8% $140.39
2022-12-06 Deutsche Bank $146 $151 +5 +2.9% $146.70
2022-08-19 Barclays Initiated $101 -32.1% $148.71
2022-07-12 Raymond James Olivia Tong Initiated $160 +11.2% $143.89
2022-05-03 D.A. Davidson $127 $123 -4 -16.6% $147.56
2022-05-03 Morgan Stanley Initiated $137 -4.4% $143.28
2022-05-03 Wells Fargo Initiated $130 -9.3% $143.28
2022-04-28 J.P. Morgan Andrea Faria Teixeira Initiated $126 -15.1% $148.34

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
5
ROE
1
ROA
5
D/E
1
P/E
3
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CLX receives an overall rating of B. Strongest factors: DCF (5/5), ROA (5/5). Areas of concern: ROE (1/5), D/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-04-21 B- B
2026-04-06 B B-
2026-03-30 B- B
2026-03-27 B B-
2026-03-26 B- B
2026-03-25 B B-
2026-03-24 B- B
2026-03-23 B B-
2026-03-17 B- B
2026-03-11 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

65 Grade C
Profitability
62
Balance Sheet
39
Earnings Quality
80
Growth
75
Value
52
Momentum
82
Safety
80
Cash Flow
60
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CLX scores highest in Momentum (82/100) and lowest in Balance Sheet (39/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.35
Safe Zone
Piotroski F-Score
5/9
Beneish M-Score
-2.51
Unlikely Manipulator
Ohlson O-Score
-5.58
Bankruptcy prob: 0.4%
Low Risk
Credit Rating
BBB+
Score: 63.9/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.30x
Accruals: -4.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CLX scores 3.35, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CLX scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CLX's score of -2.51 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CLX's implied 0.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CLX receives an estimated rating of BBB+ (score: 63.9/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CLX's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
15.24x
PEG
1.50x
P/S
1.70x
P/B
-171.93x
P/FCF
15.80x
P/OCF
12.49x
EV/EBITDA
11.49x
EV/Revenue
2.22x
EV/EBIT
13.86x
EV/FCF
19.29x
Earnings Yield
6.14%
FCF Yield
6.33%
Shareholder Yield
7.59%
Graham Number
$19.15
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 15.2x earnings, CLX trades at a reasonable valuation. An earnings yield of 6.1% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $19.15 per share, 397% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.766
NI / EBT
×
Interest Burden
0.910
EBT / EBIT
×
EBIT Margin
0.160
EBIT / Rev
×
Asset Turnover
1.195
Rev / Assets
×
Equity Multiplier
17.430
Assets / Equity
=
ROE
232.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CLX's ROE of 232.7% is driven by financial leverage (equity multiplier: 17.43x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
20.85%
Fair P/E
50.21x
Intrinsic Value
$310.93
Price/Value
0.32x
Margin of Safety
67.57%
Premium
-67.57%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CLX's realized 20.9% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $310.93, CLX appears undervalued with a 68% margin of safety. The adjusted fair P/E of 50.2x compares to the current market P/E of 15.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$95.11
Median 1Y
$87.84
5th Pctile
$55.81
95th Pctile
$139.40
Ann. Volatility
26.3%
Analyst Target
$104.22
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Linda Rendle (CEO)
and Chief Executive Officer (CEO)
$1,307,692 $9,754,753 $13,333,032
Nina Barton EVP
and Group President–Care & Connection
$646,154 $7,998,301 $10,070,862
Eric Reynolds EVP
and Chief Operating & Strategy Officer
$806,923 $2,999,828 $4,762,866
Chris Hyder EVP
and Group President–Health & Hygiene
$669,231 $2,999,203 $4,366,368
Kevin Jacobsen EVP
mer EVP and Chief Financial Officer
$650,192 $2,799,730 $4,246,342
Luc Bellet EVP
and Chief Financial Officer (CFO)
$514,776 $1,599,673 $2,622,295

CEO Pay Ratio

54:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $13,333,032
Avg Employee Cost (SGA/emp): $249,211
Employees: 7,600

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
7,600
-5.0% YoY
Revenue / Employee
$934,737
Rev: $7,104,000,000
Profit / Employee
$106,579
NI: $810,000,000
SGA / Employee
$249,211
Avg labor cost proxy
R&D / Employee
$15,921
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 1.3% 1.1% 66.3% 37.5% 69.4% 95.6% 83.8% 90.0% 15.3% 38.4% 22.2% 20.6% 61.9% 1.0% 1.3% 1.7% 2.5% 2.5% 2.4% 2.3% 2.33%
ROA 16.3% 11.3% 7.0% 3.9% 7.3% 7.4% 6.5% 7.0% 1.2% 2.5% 1.4% 1.3% 4.0% 4.8% 6.1% 7.8% 11.9% 14.3% 14.0% 13.3% 13.35%
ROIC 37.3% 30.9% 24.5% 19.0% 17.2% 16.2% 15.1% 16.0% 13.8% 20.9% 17.8% 19.8% 22.4% 22.4% 25.8% 25.5% 27.0% 29.9% 26.5% 26.1% 26.10%
ROCE 26.8% 23.2% 15.2% 9.6% 15.6% 16.1% 14.6% 15.5% 5.5% 8.5% 6.3% 6.5% 11.5% 12.0% 15.5% 17.9% 25.0% 32.3% 30.3% 29.7% 29.74%
Gross Margin 43.5% 37.2% 36.8% 32.7% 35.7% 36.5% 35.6% 36.0% 41.8% 42.8% 38.5% 43.2% 42.0% 46.2% 45.9% 43.6% 44.3% 46.5% 41.7% 43.2% 43.16%
Operating Margin 17.1% 7.9% 11.8% 6.6% 12.7% 9.6% 9.6% 8.7% 13.3% 14.2% 4.6% 16.2% 12.0% 16.8% 16.7% 13.8% 14.3% 21.1% 8.4% 14.1% 14.11%
Net Margin -3.4% 5.4% 7.9% 4.1% 8.3% 5.6% 4.9% 5.8% -11.0% 8.7% 1.6% 4.7% -2.8% 11.4% 5.6% 11.4% 11.2% 16.7% 5.6% 9.4% 9.38%
EBITDA Margin 1.0% 9.9% 14.6% 10.1% 15.4% 12.0% 11.3% 12.5% -8.2% 16.0% 8.2% 11.2% 2.3% 18.8% 14.5% 18.7% 20.1% 24.6% 13.0% 17.6% 17.63%
FCF Margin 17.3% 12.9% 8.6% 8.2% 7.9% 7.5% 9.6% 10.2% 11.7% 12.6% 11.3% 10.0% 7.9% 6.8% 9.0% 9.7% 11.4% 10.7% 9.4% 11.5% 11.51%
OCF Margin 21.7% 17.4% 12.9% 12.3% 11.7% 11.1% 13.1% 13.5% 14.8% 15.7% 14.2% 12.9% 10.9% 9.8% 12.0% 12.9% 14.6% 13.8% 12.6% 14.6% 14.56%
ROE 3Y Avg snapshot only 1.37%
ROE 5Y Avg snapshot only 1.10%
ROA 3Y Avg snapshot only 7.62%
ROIC 3Y Avg snapshot only 13.24%
ROIC Economic snapshot only 25.83%
Cash ROA snapshot only 17.69%
Cash ROIC snapshot only 32.43%
CROIC snapshot only 25.64%
NOPAT Margin snapshot only 11.72%
Pretax Margin snapshot only 14.59%
R&D / Revenue snapshot only 1.72%
SGA / Revenue snapshot only 27.17%
SBC / Revenue snapshot only 0.75%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 22.53 27.43 40.84 76.54 33.12 33.53 35.15 36.10 240.60 121.93 175.38 207.12 74.54 57.80 54.41 42.70 25.57 17.97 18.98 16.28 15.237
P/S Ratio 2.76 2.65 2.47 2.67 2.13 2.18 2.02 2.22 2.48 2.46 2.14 2.27 2.48 2.28 2.60 2.72 2.53 2.05 2.22 1.82 1.698
P/B Ratio 22.90 47.39 43.42 46.00 36.91 27.86 25.60 28.24 32.02 82.58 68.56 75.32 81.32 49.34 59.23 59.49 54.09 45.35 46.76 38.29 -171.928
P/FCF 15.94 20.61 28.79 32.59 26.94 28.95 21.00 21.78 21.20 19.54 19.00 22.76 31.38 33.51 29.04 28.07 22.15 19.13 23.60 15.80 15.800
P/OCF 12.73 15.26 19.11 21.75 18.19 19.71 15.42 16.51 16.75 15.69 15.08 17.55 22.79 23.28 21.68 21.14 17.28 14.84 17.60 12.49 12.493
EV/EBITDA 15.46 18.56 23.90 34.64 20.27 19.84 19.90 20.55 44.00 35.92 35.71 38.10 29.17 25.66 25.23 22.90 16.17 12.38 13.37 11.49 11.490
EV/Revenue 3.06 3.04 2.86 3.07 2.53 2.59 2.44 2.64 2.89 2.80 2.51 2.62 2.84 2.66 2.96 3.10 2.91 2.43 2.62 2.22 2.220
EV/EBIT 17.91 22.48 31.74 52.80 26.93 26.15 26.93 27.47 86.35 60.78 69.72 73.00 44.16 37.69 34.09 29.78 19.60 14.68 16.04 13.86 13.856
EV/FCF 17.66 23.62 33.38 37.50 32.00 34.41 25.30 25.83 24.67 22.28 22.22 26.27 35.87 39.10 33.07 31.96 25.52 22.69 27.87 19.29 19.288
Earnings Yield 4.4% 3.6% 2.4% 1.3% 3.0% 3.0% 2.8% 2.8% 0.4% 0.8% 0.6% 0.5% 1.3% 1.7% 1.8% 2.3% 3.9% 5.6% 5.3% 6.1% 6.14%
FCF Yield 6.3% 4.9% 3.5% 3.1% 3.7% 3.5% 4.8% 4.6% 4.7% 5.1% 5.3% 4.4% 3.2% 3.0% 3.4% 3.6% 4.5% 5.2% 4.2% 6.3% 6.33%
PEG Ratio snapshot only 1.500
EV/OCF snapshot only 15.250
EV/Gross Profit snapshot only 5.034
Acquirers Multiple snapshot only 14.799
Shareholder Yield snapshot only 7.59%
Graham Number snapshot only $19.15
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.42 0.89 0.89 0.89 0.89 0.97 0.97 0.97 0.97 0.95 0.95 0.95 0.95 1.03 1.03 1.03 1.03 0.84 0.84 0.84 0.838
Quick Ratio 1.10 0.52 0.52 0.52 0.52 0.54 0.54 0.54 0.54 0.59 0.59 0.59 0.59 0.63 0.63 0.63 0.63 0.57 0.57 0.57 0.565
Debt/Equity 3.44 7.70 7.70 7.70 7.70 5.58 5.58 5.58 5.58 13.29 13.29 13.29 13.29 8.85 8.85 8.85 8.85 8.97 8.97 8.97 8.972
Net Debt/Equity 2.48 6.93 6.93 6.93 6.93 5.25 5.25 5.25 5.25 11.62 11.62 11.62 11.62 8.23 8.23 8.23 8.23 8.45 8.45 8.45 8.452
Debt/Assets 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.49 0.49 0.49 0.49 0.50 0.50 0.50 0.50 0.52 0.52 0.52 0.518
Debt/EBITDA 2.09 2.63 3.66 5.04 3.56 3.34 3.60 3.42 6.59 5.07 5.92 5.82 4.17 3.94 3.31 2.99 2.30 2.06 2.17 2.21 2.205
Net Debt/EBITDA 1.51 2.37 3.29 4.53 3.20 3.15 3.39 3.22 6.20 4.43 5.18 5.09 3.65 3.67 3.08 2.78 2.14 1.94 2.05 2.08 2.077
Interest Coverage 13.84 10.68 7.01 4.48 7.43 7.26 6.43 6.58 2.18 3.31 2.48 2.50 4.50 4.86 6.30 7.54 10.43 12.00 11.39 11.16 11.165
Equity Multiplier 6.84 15.41 15.41 15.41 15.41 11.08 11.08 11.08 11.08 27.02 27.02 27.02 27.02 17.53 17.53 17.53 17.53 17.32 17.32 17.32 17.324
Cash Ratio snapshot only 0.087
Debt Service Coverage snapshot only 13.464
Cash to Debt snapshot only 0.058
FCF to Debt snapshot only 0.270
Defensive Interval snapshot only 183.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 1.33 1.17 1.15 1.13 1.13 1.14 1.13 1.13 1.15 1.22 1.16 1.21 1.19 1.21 1.28 1.23 1.20 1.26 1.20 1.19 1.195
Inventory Turnover 8.40 6.86 7.10 7.33 7.58 6.08 6.06 6.00 5.94 6.19 5.82 5.86 5.78 6.09 6.24 5.97 5.79 6.72 6.51 6.51 6.512
Receivables Turnover 11.76 11.73 11.55 11.31 11.35 11.06 10.96 11.00 11.16 10.79 10.28 10.68 10.53 10.53 11.09 10.64 10.42 9.70 9.25 9.23 9.232
Payables Turnover 7.50 5.50 5.69 5.87 6.08 4.85 4.83 4.79 4.74 4.53 4.26 4.29 4.23 4.12 4.22 4.04 3.91 4.36 4.22 4.22 4.225
DSO 31 31 32 32 32 33 33 33 33 34 36 34 35 35 33 34 35 38 39 40 39.5 days
DIO 43 53 51 50 48 60 60 61 61 59 63 62 63 60 58 61 63 54 56 56 56.0 days
DPO 49 66 64 62 60 75 76 76 77 81 86 85 86 89 86 90 93 84 86 86 86.4 days
Cash Conversion Cycle 26 18 19 20 20 18 18 18 17 12 13 11 12 6 5 5 5 8 9 9 9.2 days
Fixed Asset Turnover snapshot only 4.224
Operating Cycle snapshot only 95.6 days
Cash Velocity snapshot only 40.467
Capital Intensity snapshot only 0.823
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 18.2% 9.2% 1.4% -5.9% -5.5% -3.2% -2.6% -0.2% 0.9% 4.0% -0.1% 3.5% 0.5% -4.0% 6.2% -2.0% -2.6% 0.2% -9.3% -5.7% -5.68%
Net Income 6.1% -24.4% -62.0% -79.8% -50.4% -34.9% -7.3% 76.1% -83.8% -67.7% -78.8% -81.6% 2.2% 87.9% 3.2% 4.7% 1.9% 1.9% 1.2% 65.2% 65.21%
EPS 7.5% -22.5% -60.6% -79.1% -49.7% -34.1% -7.2% 76.0% -83.8% -68.0% -78.9% -81.7% 2.2% 87.3% 3.2% 4.7% 1.9% 1.9% 1.2% 68.9% 68.93%
FCF 35.1% -26.9% -55.4% -58.1% -56.9% -43.4% 9.4% 24.3% 49.2% 73.8% 17.1% 1.0% -32.1% -48.1% -15.7% -4.5% 40.5% 57.6% -4.9% 11.9% 11.94%
EBITDA 9.9% -17.5% -50.0% -65.8% -40.4% -22.9% -0.5% 44.3% -47.0% -37.8% -42.7% -44.6% 48.8% 27.6% 77.5% 93.2% 80.3% 89.5% 51.2% 34.6% 34.64%
Op. Income 27.0% -1.3% -31.5% -50.2% -54.1% -42.3% -32.2% -6.9% 6.9% 17.9% 10.9% 28.8% 19.6% 7.8% 53.2% 15.1% 22.0% 28.4% -12.5% -4.9% -4.88%
OCF Growth snapshot only 6.61%
Asset Growth snapshot only -3.30%
Equity Growth snapshot only -2.13%
Debt Growth snapshot only -0.79%
Shares Change snapshot only -2.20%
Dividend Growth snapshot only 0.50%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 7.4% 6.2% 5.3% 4.3% 4.2% 4.6% 4.6% 4.8% 4.1% 3.2% -0.5% -1.0% -1.4% -1.1% 1.1% 0.4% -0.4% -0.0% -1.3% -1.5% -1.47%
Revenue 5Y 5.6% 5.0% 4.5% 3.8% 3.7% 3.5% 3.1% 3.2% 3.4% 3.8% 2.6% 3.2% 2.8% 2.7% 3.9% 3.2% 2.0% 1.1% -1.0% -2.1% -2.12%
EPS 3Y 6.3% -3.2% -18.3% -31.0% -15.4% -16.4% -20.0% -18.3% -55.6% -45.3% -57.4% -59.4% -35.9% -26.6% -6.7% 22.5% 14.8% 20.6% 25.3% 20.9% 20.85%
EPS 5Y 7.5% 2.8% -6.6% -16.8% -6.1% -6.8% -9.7% -10.4% -37.2% -28.1% -36.1% -36.2% -20.6% -18.9% -14.8% -10.6% -3.9% -2.2% -6.4% -8.3% -8.32%
Net Income 3Y 4.6% -4.8% -19.6% -32.1% -16.8% -17.4% -20.7% -18.9% -56.0% -45.9% -57.9% -59.7% -36.2% -26.7% -6.5% 22.8% 14.9% 20.6% 25.0% 20.2% 20.18%
Net Income 5Y 6.5% 1.8% -7.8% -17.7% -7.2% -8.0% -10.7% -11.4% -38.0% -29.0% -36.6% -36.7% -21.3% -19.3% -15.2% -10.9% -4.4% -2.9% -7.2% -9.2% -9.23%
EBITDA 3Y 5.1% -2.6% -12.6% -21.6% -12.1% -10.6% -12.5% -11.3% -29.7% -26.6% -34.2% -35.1% -22.2% -15.1% 0.4% 15.6% 12.4% 14.6% 15.4% 13.0% 12.96%
EBITDA 5Y 3.2% -0.5% -6.8% -12.6% -6.4% -6.2% -7.8% -6.8% -18.2% -15.0% -17.5% -17.3% -11.7% -10.7% -7.4% -5.7% -1.4% -0.9% -5.2% -6.6% -6.61%
Gross Profit 3Y 8.9% 6.2% 3.3% -0.6% -2.5% -2.6% -3.0% -2.1% -2.1% -1.8% -5.4% -4.6% -4.5% -1.8% 3.9% 6.1% 7.6% 8.3% 6.5% 5.5% 5.47%
Gross Profit 5Y 6.1% 4.3% 2.4% 0.1% -0.9% -1.2% -1.8% -1.1% 0.1% 1.6% 1.0% 2.4% 2.0% 2.1% 4.0% 3.3% 2.0% 0.9% -2.1% -3.3% -3.29%
Op. Income 3Y 10.4% 3.5% -3.7% -12.2% -15.2% -13.5% -15.3% -13.6% -14.6% -12.5% -19.9% -15.8% -16.3% -9.8% 4.8% 11.4% 16.0% 17.7% 14.1% 12.1% 12.14%
Op. Income 5Y 6.9% 3.6% -1.0% -6.5% -8.2% -8.5% -10.0% -8.5% -8.0% -5.5% -7.6% -4.1% -4.9% -3.8% 0.6% -0.9% -1.9% -1.5% -7.1% -8.1% -8.15%
FCF 3Y 19.5% 6.6% -7.9% -13.9% -11.1% -12.0% -4.6% -3.8% -4.6% -10.4% -17.0% -19.3% -24.1% -20.0% 2.6% 6.2% 12.5% 12.5% -2.1% 2.6% 2.57%
FCF 5Y 14.2% 9.3% 0.7% -2.0% -1.0% -3.4% -1.6% 0.1% 1.9% 3.6% 0.0% -4.4% -6.6% -9.3% -3.0% -3.0% -3.7% -10.0% -14.5% -10.9% -10.87%
OCF 3Y 19.4% 9.4% -1.4% -7.6% -6.0% -7.5% -2.8% -3.0% -3.8% -9.2% -15.5% -17.4% -21.7% -18.3% -1.4% 2.0% 7.2% 7.7% -2.6% 1.1% 1.14%
OCF 5Y 14.6% 10.4% 3.1% 0.1% 0.5% -2.0% -0.7% 0.7% 2.1% 3.5% 0.5% -3.0% -4.8% -6.9% -2.3% -2.4% -3.0% -8.7% -12.4% -10.1% -10.11%
Assets 3Y 10.8% 7.8% 7.8% 7.8% 7.8% 6.4% 6.4% 6.4% 6.4% -1.5% -1.5% -1.5% -1.5% -3.2% -3.2% -3.2% -3.2% -3.3% -3.3% -3.3% -3.34%
Assets 5Y 8.3% 7.0% 7.0% 7.0% 7.0% 6.1% 6.1% 6.1% 6.1% 3.3% 3.3% 3.3% 3.3% 2.4% 2.4% 2.4% 2.4% -2.2% -2.2% -2.2% -2.19%
Equity 3Y 18.8% -17.3% -17.3% -17.3% -17.3% -0.2% -0.2% -0.2% -0.2% -37.7% -37.7% -37.7% -37.7% -7.2% -7.2% -7.2% -7.2% -16.7% -16.7% -16.7% -16.73%
Book Value 3Y 20.7% -15.9% -16.0% -15.9% -15.9% 1.0% 0.8% 0.6% 0.8% -37.0% -37.0% -37.1% -37.4% -7.2% -7.4% -7.4% -7.3% -16.7% -16.5% -16.3% -16.26%
Dividend 3Y 3.7% 3.3% 2.8% 2.6% 2.4% 2.0% 1.8% 1.6% 1.8% 1.7% 1.8% 1.7% 1.1% 0.8% 0.4% 0.3% 0.5% 0.4% 0.5% 0.7% 0.73%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.77 0.88 0.83 0.67 0.74 0.85 0.73 0.55 0.64 0.85 0.53 0.44 0.41 0.51 0.73 0.75 0.57 0.37 0.03 0.67 0.666
Earnings Stability 0.91 0.26 0.00 0.02 0.04 0.22 0.22 0.23 0.57 0.72 0.64 0.51 0.72 0.82 0.60 0.42 0.26 0.15 0.11 0.07 0.074
Margin Stability 0.98 0.98 0.95 0.92 0.90 0.90 0.89 0.89 0.89 0.90 0.90 0.89 0.90 0.91 0.91 0.91 0.90 0.90 0.89 0.90 0.903
Rev. Growth Consistency 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.50 1.00 0.00 0.50 0.00 0.00 0.50 0.00 0.00 0.000
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.98 0.90 0.50 0.50 0.50 0.86 0.97 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.94 0.72 0.10 0.00 0.33 0.58 0.92 0.45 0.00 0.00 0.00 0.00 0.00 0.39 0.00 0.00 0.03 0.03 0.24 0.51 0.508
ROE Trend -0.31 0.48 -0.30 -0.80 -0.17 -0.55 -0.44 -0.19 -0.93 -0.60 -0.50 -0.33 0.47 0.10 0.53 0.82 1.50 1.76 1.72 1.47 1.474
Gross Margin Trend 0.02 -0.01 -0.05 -0.08 -0.10 -0.09 -0.09 -0.06 -0.03 -0.00 0.02 0.05 0.05 0.05 0.07 0.06 0.05 0.04 0.02 0.01 0.010
FCF Margin Trend 0.03 -0.03 -0.07 -0.08 -0.08 -0.09 -0.04 -0.03 -0.01 0.02 0.02 0.01 -0.02 -0.03 -0.02 -0.00 0.02 0.01 -0.01 0.02 0.017
Sustainable Growth Rate 50.3% 23.0% -18.7% -47.9% -16.4% -22.5% -35.0% -29.4% -1.0% -1.1% -1.3% -1.3% -90.7% -1.1% -87.6% -51.8% 33.9% 64.1% 58.2% 47.1% 47.15%
Internal Growth Rate 7.0% 2.5% 1.6% 3.8% 3.5% 2.8% 2.78%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.77 1.80 2.14 3.52 1.82 1.70 2.28 2.19 14.36 7.77 11.63 11.80 3.27 2.48 2.51 2.02 1.48 1.21 1.08 1.30 1.303
FCF/OCF 0.80 0.74 0.66 0.67 0.68 0.68 0.73 0.76 0.79 0.80 0.79 0.77 0.73 0.69 0.75 0.75 0.78 0.78 0.75 0.79 0.791
FCF/Net Income snapshot only 1.030
OCF/EBITDA snapshot only 0.753
CapEx/Revenue 4.4% 4.5% 4.3% 4.1% 3.8% 3.5% 3.5% 3.3% 3.1% 3.1% 2.9% 3.0% 3.0% 3.0% 3.0% 3.2% 3.2% 3.1% 3.2% 3.0% 3.05%
CapEx/Depreciation snapshot only 0.924
Accruals Ratio -0.13 -0.09 -0.08 -0.10 -0.06 -0.05 -0.08 -0.08 -0.16 -0.17 -0.15 -0.14 -0.09 -0.07 -0.09 -0.08 -0.06 -0.03 -0.01 -0.04 -0.040
Sloan Accruals snapshot only -0.103
Cash Flow Adequacy snapshot only 1.218
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 2.7% 2.9% 3.1% 3.0% 3.7% 3.7% 4.0% 3.7% 3.3% 3.2% 3.9% 3.6% 3.3% 3.7% 3.1% 3.1% 3.4% 4.1% 4.0% 4.9% 5.23%
Dividend/Share $4.41 $4.45 $4.51 $4.54 $4.57 $4.61 $4.63 $4.65 $4.69 $4.68 $4.71 $4.73 $4.76 $4.76 $4.79 $4.80 $4.84 $4.86 $4.89 $4.94 $4.96
Payout Ratio 60.0% 78.6% 1.3% 2.3% 1.2% 1.2% 1.4% 1.3% 7.8% 3.9% 6.8% 7.4% 2.5% 2.1% 1.7% 1.3% 86.6% 74.3% 76.1% 79.7% 79.74%
FCF Payout Ratio 42.5% 59.0% 90.3% 97.1% 1.0% 1.1% 84.7% 80.0% 69.0% 62.7% 73.9% 81.0% 1.0% 1.2% 89.2% 86.2% 75.0% 79.1% 94.7% 77.4% 77.38%
Total Payout Ratio 1.3% 2.1% 3.2% 4.8% 1.9% 1.3% 1.4% 1.3% 7.8% 3.9% 6.8% 7.4% 2.5% 2.1% 2.0% 1.9% 1.2% 1.2% 1.2% 1.2% 1.24%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.09 0.08 0.07 0.06 0.06 0.06 0.07 0.06 0.06 0.05 0.06 0.06 0.05 0.06 0.05 0.05 0.05 0.05 0.05 0.05 0.054
Buyback Yield 3.0% 4.6% 4.7% 3.3% 2.1% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.6% 1.3% 1.4% 2.3% 2.4% 2.7% 2.69%
Net Buyback Yield 2.4% 4.1% 4.1% 3.2% 2.1% 0.1% -0.1% -0.1% -0.1% -0.2% -0.3% -0.2% -0.1% -0.0% 0.5% 1.2% 1.3% 2.1% 2.3% 2.6% 2.55%
Total Shareholder Return 5.0% 7.0% 7.2% 6.2% 5.8% 3.8% 3.9% 3.6% 3.2% 3.0% 3.6% 3.4% 3.2% 3.7% 3.5% 4.2% 4.7% 6.2% 6.3% 7.5% 7.45%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.77 0.79 0.78 0.77 0.79 0.76 0.75 0.76 0.57 0.63 0.57 0.51 0.67 0.70 0.65 0.71 0.74 0.75 0.78 0.77 0.766
Interest Burden (EBT/EBIT) 0.93 0.91 0.86 0.78 0.87 0.86 0.84 0.85 0.54 0.70 0.60 0.60 0.78 0.79 0.84 0.87 0.90 0.92 0.91 0.91 0.910
EBIT Margin 0.17 0.14 0.09 0.06 0.09 0.10 0.09 0.10 0.03 0.05 0.04 0.04 0.06 0.07 0.09 0.10 0.15 0.17 0.16 0.16 0.160
Asset Turnover 1.33 1.17 1.15 1.13 1.13 1.14 1.13 1.13 1.15 1.22 1.16 1.21 1.19 1.21 1.28 1.23 1.20 1.26 1.20 1.19 1.195
Equity Multiplier 7.72 9.51 9.51 9.51 9.51 12.92 12.92 12.92 12.92 15.60 15.60 15.60 15.60 21.34 21.34 21.34 21.34 17.43 17.43 17.43 17.430
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $7.35 $5.66 $3.52 $1.99 $3.70 $3.73 $3.27 $3.51 $0.60 $1.20 $0.69 $0.64 $1.93 $2.24 $2.86 $3.67 $5.59 $6.55 $6.43 $6.19 $6.19
Book Value/Share $7.23 $3.28 $3.31 $3.32 $3.32 $4.49 $4.49 $4.48 $4.50 $1.77 $1.76 $1.77 $1.77 $2.62 $2.63 $2.63 $2.64 $2.59 $2.61 $2.63 $0.76
Tangible Book/Share $-12.44 $-16.60 $-16.78 $-16.80 $-16.81 $-15.23 $-15.22 $-15.21 $-15.25 $-13.99 $-13.99 $-13.99 $-14.04 $-12.64 $-12.68 $-12.68 $-12.74 $-11.91 $-11.98 $-12.09 $-12.09
Revenue/Share $59.88 $58.55 $58.29 $57.14 $57.38 $57.41 $56.82 $56.98 $57.99 $59.28 $56.44 $58.66 $58.02 $56.72 $59.91 $57.48 $56.57 $57.41 $55.04 $55.43 $55.70
FCF/Share $10.39 $7.54 $5.00 $4.68 $4.54 $4.32 $5.47 $5.82 $6.79 $7.46 $6.37 $5.84 $4.59 $3.86 $5.37 $5.58 $6.46 $6.15 $5.17 $6.38 $3.13
OCF/Share $13.00 $10.18 $7.53 $7.01 $6.73 $6.35 $7.45 $7.67 $8.60 $9.29 $8.02 $7.58 $6.32 $5.56 $7.19 $7.40 $8.28 $7.93 $6.93 $8.07 $4.75
Cash/Share $6.93 $2.54 $2.57 $2.57 $2.58 $1.48 $1.48 $1.48 $1.48 $2.94 $2.94 $2.94 $2.95 $1.62 $1.62 $1.62 $1.63 $1.35 $1.36 $1.37 $9.78
EBITDA/Share $11.87 $9.59 $6.98 $5.07 $7.18 $7.50 $6.96 $7.31 $3.81 $4.63 $3.96 $4.03 $5.64 $5.89 $7.03 $7.78 $10.19 $11.27 $10.78 $10.71 $10.71
Debt/Share $24.85 $25.25 $25.52 $25.55 $25.56 $25.07 $25.04 $25.03 $25.10 $23.46 $23.46 $23.46 $23.53 $23.21 $23.28 $23.29 $23.40 $23.27 $23.41 $23.62 $23.62
Net Debt/Share $17.92 $22.71 $22.95 $22.98 $22.98 $23.59 $23.56 $23.55 $23.62 $20.51 $20.51 $20.52 $20.58 $21.60 $21.66 $21.67 $21.77 $21.92 $22.05 $22.25 $22.25
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score 3.352
Altman Z-Prime snapshot only 3.736
Piotroski F-Score 7 6 6 5 5 5 5 7 7 5 5 5 6 6 7 6 7 7 5 5 5
Beneish M-Score -2.96 -2.82 -2.75 -2.78 -2.67 -2.60 -2.75 -2.83 -3.25 -3.39 -3.28 -3.27 -2.95 -2.84 -2.92 -2.83 -2.75 -2.46 -2.27 -2.51 -2.508
Ohlson O-Score snapshot only -5.579
Net-Net WC snapshot only $-28.47
EVA snapshot only $488466125.76
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 76.12 66.21 62.76 51.09 60.85 61.23 58.02 56.06 43.58 56.76 43.57 43.50 49.69 48.82 57.07 61.66 64.06 63.92 65.07 63.86 63.863
Credit Grade snapshot only 8
Credit Trend snapshot only 2.208
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 47
Sector Credit Rank snapshot only 55

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms